Epitope Mapping of SARS-CoV-2 Spike Antibodies in Vaccinated Kidney Transplant Recipients Reveals Poor Spike Coverage Compared to Healthy Controls Article Swipe
Andrew H. Karaba
,
William R. Morgenlander
,
Trevor S. Johnston
,
Camille Hage
,
Andrew Pekosz
,
Christine M. Durand
,
Dorry L. Segev
,
Mark A. Robien
,
Peter S. Heeger
,
Christian P. Larsen
,
Joel N. Blankson
,
William A. Werbel
,
H. Benjamin Larman
,
Aaron A.R. Tobian
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1093/infdis/jiad534
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1093/infdis/jiad534
Kidney transplant recipients (KTRs) develop decreased antibody titers to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination compared to healthy controls (HCs), but whether KTRs generate antibodies against key epitopes associated with neutralization is unknown. Plasma from 78 KTRs from a clinical trial of third doses of SARS-CoV-2 vaccines and 12 HCs underwent phage display immunoprecipitation and sequencing (PhIP-Seq) to map antibody responses against SARS-CoV-2. KTRs had lower antibody reactivity to SARS-CoV-2 than HCs, but KTRs and HCs recognized similar epitopes associated with neutralization. Thus, epitope gaps in antibody breadth of KTRs are unlikely responsible for decreased efficacy of SARS-CoV-2 vaccines in this immunosuppressed population. Clinical Trials Registration. NCT04969263.
Related Topics
Concepts
Epitope
Antibody
Medicine
Virology
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Immunology
Neutralization
Epitope mapping
Population
Titer
Vaccination
Coronavirus
Coronavirus disease 2019 (COVID-19)
Internal medicine
Disease
Infectious disease (medical specialty)
Environmental health
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1093/infdis/jiad534
- https://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiad534/54450191/jiad534.pdf
- OA Status
- bronze
- Cited By
- 2
- References
- 15
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4389131630
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4389131630Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1093/infdis/jiad534Digital Object Identifier
- Title
-
Epitope Mapping of SARS-CoV-2 Spike Antibodies in Vaccinated Kidney Transplant Recipients Reveals Poor Spike Coverage Compared to Healthy ControlsWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-11-29Full publication date if available
- Authors
-
Andrew H. Karaba, William R. Morgenlander, Trevor S. Johnston, Camille Hage, Andrew Pekosz, Christine M. Durand, Dorry L. Segev, Mark A. Robien, Peter S. Heeger, Christian P. Larsen, Joel N. Blankson, William A. Werbel, H. Benjamin Larman, Aaron A.R. TobianList of authors in order
- Landing page
-
https://doi.org/10.1093/infdis/jiad534Publisher landing page
- PDF URL
-
https://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiad534/54450191/jiad534.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiad534/54450191/jiad534.pdfDirect OA link when available
- Concepts
-
Epitope, Antibody, Medicine, Virology, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Immunology, Neutralization, Epitope mapping, Population, Titer, Vaccination, Coronavirus, Coronavirus disease 2019 (COVID-19), Internal medicine, Disease, Infectious disease (medical specialty), Environmental healthTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
2Total citation count in OpenAlex
- Citations by year (recent)
-
2024: 2Per-year citation counts (last 5 years)
- References (count)
-
15Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4389131630 |
|---|---|
| doi | https://doi.org/10.1093/infdis/jiad534 |
| ids.doi | https://doi.org/10.1093/infdis/jiad534 |
| ids.openalex | https://openalex.org/W4389131630 |
| fwci | 0.56334932 |
| type | article |
| title | Epitope Mapping of SARS-CoV-2 Spike Antibodies in Vaccinated Kidney Transplant Recipients Reveals Poor Spike Coverage Compared to Healthy Controls |
| awards[0].id | https://openalex.org/G3728719625 |
| awards[0].funder_id | https://openalex.org/F4320332161 |
| awards[0].display_name | |
| awards[0].funder_award_id | U01 AI138897 |
| awards[0].funder_display_name | National Institutes of Health |
| awards[1].id | https://openalex.org/G4337186920 |
| awards[1].funder_id | https://openalex.org/F4320332161 |
| awards[1].display_name | |
| awards[1].funder_award_id | R01 DK131926 |
| awards[1].funder_display_name | National Institutes of Health |
| awards[2].id | https://openalex.org/G7153956294 |
| awards[2].funder_id | https://openalex.org/F4320332161 |
| awards[2].display_name | |
| awards[2].funder_award_id | U01 AI134591 |
| awards[2].funder_display_name | National Institutes of Health |
| awards[3].id | https://openalex.org/G109185172 |
| awards[3].funder_id | https://openalex.org/F4320332161 |
| awards[3].display_name | |
| awards[3].funder_award_id | R01 GM136724 |
| awards[3].funder_display_name | National Institutes of Health |
| awards[4].id | https://openalex.org/G176900268 |
| awards[4].funder_id | https://openalex.org/F4320332161 |
| awards[4].display_name | |
| awards[4].funder_award_id | K23 AI157893 |
| awards[4].funder_display_name | National Institutes of Health |
| awards[5].id | https://openalex.org/G1088122786 |
| awards[5].funder_id | https://openalex.org/F4320332161 |
| awards[5].display_name | |
| awards[5].funder_award_id | K08 AI156021 |
| awards[5].funder_display_name | National Institutes of Health |
| biblio.issue | 5 |
| biblio.volume | 229 |
| biblio.last_page | 1371 |
| biblio.first_page | 1366 |
| grants[0].funder | https://openalex.org/F4320332161 |
| grants[0].award_id | K08 AI156021 |
| grants[0].funder_display_name | National Institutes of Health |
| grants[1].funder | https://openalex.org/F4320332161 |
| grants[1].award_id | K23 AI157893 |
| grants[1].funder_display_name | National Institutes of Health |
| grants[2].funder | https://openalex.org/F4320332161 |
| grants[2].award_id | R01 DK131926 |
| grants[2].funder_display_name | National Institutes of Health |
| grants[3].funder | https://openalex.org/F4320332161 |
| grants[3].award_id | R01 GM136724 |
| grants[3].funder_display_name | National Institutes of Health |
| grants[4].funder | https://openalex.org/F4320332161 |
| grants[4].award_id | U01 AI134591 |
| grants[4].funder_display_name | National Institutes of Health |
| grants[5].funder | https://openalex.org/F4320332161 |
| grants[5].award_id | U01 AI138897 |
| grants[5].funder_display_name | National Institutes of Health |
| topics[0].id | https://openalex.org/T10118 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | SARS-CoV-2 and COVID-19 Research |
| topics[1].id | https://openalex.org/T11495 |
| topics[1].field.id | https://openalex.org/fields/11 |
| topics[1].field.display_name | Agricultural and Biological Sciences |
| topics[1].score | 0.9922000169754028 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1103 |
| topics[1].subfield.display_name | Animal Science and Zoology |
| topics[1].display_name | Animal Virus Infections Studies |
| topics[2].id | https://openalex.org/T10993 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9908999800682068 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2403 |
| topics[2].subfield.display_name | Immunology |
| topics[2].display_name | Complement system in diseases |
| funders[0].id | https://openalex.org/F4320332161 |
| funders[0].ror | https://ror.org/01cwqze88 |
| funders[0].display_name | National Institutes of Health |
| is_xpac | False |
| apc_list.value | 4320 |
| apc_list.currency | USD |
| apc_list.value_usd | 4320 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C195616568 |
| concepts[0].level | 3 |
| concepts[0].score | 0.8124504685401917 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q128711 |
| concepts[0].display_name | Epitope |
| concepts[1].id | https://openalex.org/C159654299 |
| concepts[1].level | 2 |
| concepts[1].score | 0.721004843711853 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q79460 |
| concepts[1].display_name | Antibody |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.7003467082977295 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C159047783 |
| concepts[3].level | 1 |
| concepts[3].score | 0.6342911720275879 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[3].display_name | Virology |
| concepts[4].id | https://openalex.org/C3007834351 |
| concepts[4].level | 5 |
| concepts[4].score | 0.6016998291015625 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q82069695 |
| concepts[4].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| concepts[5].id | https://openalex.org/C203014093 |
| concepts[5].level | 1 |
| concepts[5].score | 0.5073370337486267 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[5].display_name | Immunology |
| concepts[6].id | https://openalex.org/C14086860 |
| concepts[6].level | 3 |
| concepts[6].score | 0.493897020816803 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q337120 |
| concepts[6].display_name | Neutralization |
| concepts[7].id | https://openalex.org/C2781241564 |
| concepts[7].level | 4 |
| concepts[7].score | 0.48391443490982056 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1347450 |
| concepts[7].display_name | Epitope mapping |
| concepts[8].id | https://openalex.org/C2908647359 |
| concepts[8].level | 2 |
| concepts[8].score | 0.4686640501022339 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q2625603 |
| concepts[8].display_name | Population |
| concepts[9].id | https://openalex.org/C32611913 |
| concepts[9].level | 3 |
| concepts[9].score | 0.43449926376342773 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q2166189 |
| concepts[9].display_name | Titer |
| concepts[10].id | https://openalex.org/C22070199 |
| concepts[10].level | 2 |
| concepts[10].score | 0.43125012516975403 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q192995 |
| concepts[10].display_name | Vaccination |
| concepts[11].id | https://openalex.org/C2777648638 |
| concepts[11].level | 5 |
| concepts[11].score | 0.42605969309806824 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q57751738 |
| concepts[11].display_name | Coronavirus |
| concepts[12].id | https://openalex.org/C3008058167 |
| concepts[12].level | 4 |
| concepts[12].score | 0.3328792452812195 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q84263196 |
| concepts[12].display_name | Coronavirus disease 2019 (COVID-19) |
| concepts[13].id | https://openalex.org/C126322002 |
| concepts[13].level | 1 |
| concepts[13].score | 0.16515371203422546 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[13].display_name | Internal medicine |
| concepts[14].id | https://openalex.org/C2779134260 |
| concepts[14].level | 2 |
| concepts[14].score | 0.08948257565498352 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[14].display_name | Disease |
| concepts[15].id | https://openalex.org/C524204448 |
| concepts[15].level | 3 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q788926 |
| concepts[15].display_name | Infectious disease (medical specialty) |
| concepts[16].id | https://openalex.org/C99454951 |
| concepts[16].level | 1 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[16].display_name | Environmental health |
| keywords[0].id | https://openalex.org/keywords/epitope |
| keywords[0].score | 0.8124504685401917 |
| keywords[0].display_name | Epitope |
| keywords[1].id | https://openalex.org/keywords/antibody |
| keywords[1].score | 0.721004843711853 |
| keywords[1].display_name | Antibody |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.7003467082977295 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/virology |
| keywords[3].score | 0.6342911720275879 |
| keywords[3].display_name | Virology |
| keywords[4].id | https://openalex.org/keywords/severe-acute-respiratory-syndrome-coronavirus-2 |
| keywords[4].score | 0.6016998291015625 |
| keywords[4].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| keywords[5].id | https://openalex.org/keywords/immunology |
| keywords[5].score | 0.5073370337486267 |
| keywords[5].display_name | Immunology |
| keywords[6].id | https://openalex.org/keywords/neutralization |
| keywords[6].score | 0.493897020816803 |
| keywords[6].display_name | Neutralization |
| keywords[7].id | https://openalex.org/keywords/epitope-mapping |
| keywords[7].score | 0.48391443490982056 |
| keywords[7].display_name | Epitope mapping |
| keywords[8].id | https://openalex.org/keywords/population |
| keywords[8].score | 0.4686640501022339 |
| keywords[8].display_name | Population |
| keywords[9].id | https://openalex.org/keywords/titer |
| keywords[9].score | 0.43449926376342773 |
| keywords[9].display_name | Titer |
| keywords[10].id | https://openalex.org/keywords/vaccination |
| keywords[10].score | 0.43125012516975403 |
| keywords[10].display_name | Vaccination |
| keywords[11].id | https://openalex.org/keywords/coronavirus |
| keywords[11].score | 0.42605969309806824 |
| keywords[11].display_name | Coronavirus |
| keywords[12].id | https://openalex.org/keywords/coronavirus-disease-2019 |
| keywords[12].score | 0.3328792452812195 |
| keywords[12].display_name | Coronavirus disease 2019 (COVID-19) |
| keywords[13].id | https://openalex.org/keywords/internal-medicine |
| keywords[13].score | 0.16515371203422546 |
| keywords[13].display_name | Internal medicine |
| keywords[14].id | https://openalex.org/keywords/disease |
| keywords[14].score | 0.08948257565498352 |
| keywords[14].display_name | Disease |
| language | en |
| locations[0].id | doi:10.1093/infdis/jiad534 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S54542293 |
| locations[0].source.issn | 0022-1899, 1537-6613 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0022-1899 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | The Journal of Infectious Diseases |
| locations[0].source.host_organization | https://openalex.org/P4310311648 |
| locations[0].source.host_organization_name | Oxford University Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| locations[0].source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| locations[0].license | |
| locations[0].pdf_url | https://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiad534/54450191/jiad534.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | The Journal of Infectious Diseases |
| locations[0].landing_page_url | https://doi.org/10.1093/infdis/jiad534 |
| locations[1].id | pmh:oai:pubmedcentral.nih.gov:11095532 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S2764455111 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed Central |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | J Infect Dis |
| locations[1].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11095532 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5069380959 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-2785-317X |
| authorships[0].author.display_name | Andrew H. Karaba |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I145311948, https://openalex.org/I2799853436 |
| authorships[0].affiliations[0].raw_affiliation_string | Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA |
| authorships[0].institutions[0].id | https://openalex.org/I2799853436 |
| authorships[0].institutions[0].ror | https://ror.org/037zgn354 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I2799853436 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Johns Hopkins Medicine |
| authorships[0].institutions[1].id | https://openalex.org/I145311948 |
| authorships[0].institutions[1].ror | https://ror.org/00za53h95 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I145311948 |
| authorships[0].institutions[1].country_code | US |
| authorships[0].institutions[1].display_name | Johns Hopkins University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Andrew H Karaba |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA |
| authorships[1].author.id | https://openalex.org/A5012764036 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-7205-3732 |
| authorships[1].author.display_name | William R. Morgenlander |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I145311948, https://openalex.org/I2799853436 |
| authorships[1].affiliations[0].raw_affiliation_string | Institute for Cell Engineering, Division of Immunology, Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA |
| authorships[1].institutions[0].id | https://openalex.org/I2799853436 |
| authorships[1].institutions[0].ror | https://ror.org/037zgn354 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I2799853436 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Johns Hopkins Medicine |
| authorships[1].institutions[1].id | https://openalex.org/I145311948 |
| authorships[1].institutions[1].ror | https://ror.org/00za53h95 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I145311948 |
| authorships[1].institutions[1].country_code | US |
| authorships[1].institutions[1].display_name | Johns Hopkins University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | William R Morgenlander |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Institute for Cell Engineering, Division of Immunology, Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA |
| authorships[2].author.id | https://openalex.org/A5018414374 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-8662-541X |
| authorships[2].author.display_name | Trevor S. Johnston |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I145311948, https://openalex.org/I2799853436 |
| authorships[2].affiliations[0].raw_affiliation_string | Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA |
| authorships[2].institutions[0].id | https://openalex.org/I2799853436 |
| authorships[2].institutions[0].ror | https://ror.org/037zgn354 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I2799853436 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Johns Hopkins Medicine |
| authorships[2].institutions[1].id | https://openalex.org/I145311948 |
| authorships[2].institutions[1].ror | https://ror.org/00za53h95 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I145311948 |
| authorships[2].institutions[1].country_code | US |
| authorships[2].institutions[1].display_name | Johns Hopkins University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Trevor S Johnston |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA |
| authorships[3].author.id | https://openalex.org/A5008276177 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-6652-0725 |
| authorships[3].author.display_name | Camille Hage |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I145311948, https://openalex.org/I2799853436 |
| authorships[3].affiliations[0].raw_affiliation_string | Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA |
| authorships[3].institutions[0].id | https://openalex.org/I2799853436 |
| authorships[3].institutions[0].ror | https://ror.org/037zgn354 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I2799853436 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Johns Hopkins Medicine |
| authorships[3].institutions[1].id | https://openalex.org/I145311948 |
| authorships[3].institutions[1].ror | https://ror.org/00za53h95 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I145311948 |
| authorships[3].institutions[1].country_code | US |
| authorships[3].institutions[1].display_name | Johns Hopkins University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Camille Hage |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA |
| authorships[4].author.id | https://openalex.org/A5066093013 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-3248-1761 |
| authorships[4].author.display_name | Andrew Pekosz |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I145311948, https://openalex.org/I2799853436 |
| authorships[4].affiliations[0].raw_affiliation_string | Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I145311948 |
| authorships[4].affiliations[1].raw_affiliation_string | W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health , Baltimore, Maryland , USA |
| authorships[4].institutions[0].id | https://openalex.org/I2799853436 |
| authorships[4].institutions[0].ror | https://ror.org/037zgn354 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I2799853436 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Johns Hopkins Medicine |
| authorships[4].institutions[1].id | https://openalex.org/I145311948 |
| authorships[4].institutions[1].ror | https://ror.org/00za53h95 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I145311948 |
| authorships[4].institutions[1].country_code | US |
| authorships[4].institutions[1].display_name | Johns Hopkins University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Andrew Pekosz |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA, W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health , Baltimore, Maryland , USA |
| authorships[5].author.id | https://openalex.org/A5011890756 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-2605-9257 |
| authorships[5].author.display_name | Christine M. Durand |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I145311948, https://openalex.org/I2799853436 |
| authorships[5].affiliations[0].raw_affiliation_string | Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA |
| authorships[5].institutions[0].id | https://openalex.org/I2799853436 |
| authorships[5].institutions[0].ror | https://ror.org/037zgn354 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I2799853436 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Johns Hopkins Medicine |
| authorships[5].institutions[1].id | https://openalex.org/I145311948 |
| authorships[5].institutions[1].ror | https://ror.org/00za53h95 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I145311948 |
| authorships[5].institutions[1].country_code | US |
| authorships[5].institutions[1].display_name | Johns Hopkins University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Christine M Durand |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA |
| authorships[6].author.id | https://openalex.org/A5030533822 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-1924-4801 |
| authorships[6].author.display_name | Dorry L. Segev |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I57206974 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Surgery, NewYork University Grossman School of Medicine , New York, New York , USA |
| authorships[6].institutions[0].id | https://openalex.org/I57206974 |
| authorships[6].institutions[0].ror | https://ror.org/0190ak572 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I57206974 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | New York University |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Dorry L Segev |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Surgery, NewYork University Grossman School of Medicine , New York, New York , USA |
| authorships[7].author.id | https://openalex.org/A5006259060 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-0403-0955 |
| authorships[7].author.display_name | Mark A. Robien |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210134534 |
| authorships[7].affiliations[0].raw_affiliation_string | Transplantation Branch, Division of Allergy Immunology and Transplantation, National Institute of Allergy and Infectious Diseases , Rockville, Maryland , USA |
| authorships[7].institutions[0].id | https://openalex.org/I4210134534 |
| authorships[7].institutions[0].ror | https://ror.org/043z4tv69 |
| authorships[7].institutions[0].type | facility |
| authorships[7].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1299303238, https://openalex.org/I4210134534 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | National Institute of Allergy and Infectious Diseases |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Mark A Robien |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Transplantation Branch, Division of Allergy Immunology and Transplantation, National Institute of Allergy and Infectious Diseases , Rockville, Maryland , USA |
| authorships[8].author.id | https://openalex.org/A5088980123 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-4673-6913 |
| authorships[8].author.display_name | Peter S. Heeger |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I1282927834 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Medicine, Comprehensive Transplant Center, Cedars-Sinai Medical Center , Los Angeles California , USA |
| authorships[8].institutions[0].id | https://openalex.org/I1282927834 |
| authorships[8].institutions[0].ror | https://ror.org/02pammg90 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I1282927834 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | Cedars-Sinai Medical Center |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Peter S Heeger |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Medicine, Comprehensive Transplant Center, Cedars-Sinai Medical Center , Los Angeles California , USA |
| authorships[9].author.id | https://openalex.org/A5062306820 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-6573-2649 |
| authorships[9].author.display_name | Christian P. Larsen |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I150468666 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Medicine, Emory University , Atlanta, Georgia , USA |
| authorships[9].institutions[0].id | https://openalex.org/I150468666 |
| authorships[9].institutions[0].ror | https://ror.org/03czfpz43 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I150468666 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Emory University |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Christian P Larsen |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Medicine, Emory University , Atlanta, Georgia , USA |
| authorships[10].author.id | https://openalex.org/A5018624004 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-9683-8021 |
| authorships[10].author.display_name | Joel N. Blankson |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I145311948, https://openalex.org/I2799853436 |
| authorships[10].affiliations[0].raw_affiliation_string | Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA |
| authorships[10].institutions[0].id | https://openalex.org/I2799853436 |
| authorships[10].institutions[0].ror | https://ror.org/037zgn354 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I2799853436 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | Johns Hopkins Medicine |
| authorships[10].institutions[1].id | https://openalex.org/I145311948 |
| authorships[10].institutions[1].ror | https://ror.org/00za53h95 |
| authorships[10].institutions[1].type | education |
| authorships[10].institutions[1].lineage | https://openalex.org/I145311948 |
| authorships[10].institutions[1].country_code | US |
| authorships[10].institutions[1].display_name | Johns Hopkins University |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Joel N Blankson |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA |
| authorships[11].author.id | https://openalex.org/A5043750897 |
| authorships[11].author.orcid | https://orcid.org/0000-0003-2943-5895 |
| authorships[11].author.display_name | William A. Werbel |
| authorships[11].countries | US |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I145311948, https://openalex.org/I2799853436 |
| authorships[11].affiliations[0].raw_affiliation_string | Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA |
| authorships[11].institutions[0].id | https://openalex.org/I2799853436 |
| authorships[11].institutions[0].ror | https://ror.org/037zgn354 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I2799853436 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | Johns Hopkins Medicine |
| authorships[11].institutions[1].id | https://openalex.org/I145311948 |
| authorships[11].institutions[1].ror | https://ror.org/00za53h95 |
| authorships[11].institutions[1].type | education |
| authorships[11].institutions[1].lineage | https://openalex.org/I145311948 |
| authorships[11].institutions[1].country_code | US |
| authorships[11].institutions[1].display_name | Johns Hopkins University |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | William A Werbel |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA |
| authorships[12].author.id | https://openalex.org/A5059663009 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-7863-196X |
| authorships[12].author.display_name | H. Benjamin Larman |
| authorships[12].countries | US |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I145311948, https://openalex.org/I2799853436 |
| authorships[12].affiliations[0].raw_affiliation_string | Institute for Cell Engineering, Division of Immunology, Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA |
| authorships[12].institutions[0].id | https://openalex.org/I2799853436 |
| authorships[12].institutions[0].ror | https://ror.org/037zgn354 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I2799853436 |
| authorships[12].institutions[0].country_code | US |
| authorships[12].institutions[0].display_name | Johns Hopkins Medicine |
| authorships[12].institutions[1].id | https://openalex.org/I145311948 |
| authorships[12].institutions[1].ror | https://ror.org/00za53h95 |
| authorships[12].institutions[1].type | education |
| authorships[12].institutions[1].lineage | https://openalex.org/I145311948 |
| authorships[12].institutions[1].country_code | US |
| authorships[12].institutions[1].display_name | Johns Hopkins University |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | H Benjamin Larman |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Institute for Cell Engineering, Division of Immunology, Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA |
| authorships[13].author.id | https://openalex.org/A5066564090 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-0517-3766 |
| authorships[13].author.display_name | Aaron A.R. Tobian |
| authorships[13].countries | US |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I145311948, https://openalex.org/I2799853436 |
| authorships[13].affiliations[0].raw_affiliation_string | Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA |
| authorships[13].institutions[0].id | https://openalex.org/I2799853436 |
| authorships[13].institutions[0].ror | https://ror.org/037zgn354 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I2799853436 |
| authorships[13].institutions[0].country_code | US |
| authorships[13].institutions[0].display_name | Johns Hopkins Medicine |
| authorships[13].institutions[1].id | https://openalex.org/I145311948 |
| authorships[13].institutions[1].ror | https://ror.org/00za53h95 |
| authorships[13].institutions[1].type | education |
| authorships[13].institutions[1].lineage | https://openalex.org/I145311948 |
| authorships[13].institutions[1].country_code | US |
| authorships[13].institutions[1].display_name | Johns Hopkins University |
| authorships[13].author_position | last |
| authorships[13].raw_author_name | Aaron A R Tobian |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiad534/54450191/jiad534.pdf |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Epitope Mapping of SARS-CoV-2 Spike Antibodies in Vaccinated Kidney Transplant Recipients Reveals Poor Spike Coverage Compared to Healthy Controls |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10118 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | SARS-CoV-2 and COVID-19 Research |
| related_works | https://openalex.org/W1977627421, https://openalex.org/W2996280882, https://openalex.org/W2312755390, https://openalex.org/W4391692848, https://openalex.org/W3189724180, https://openalex.org/W2471846512, https://openalex.org/W4214932605, https://openalex.org/W2393351343, https://openalex.org/W2019166448, https://openalex.org/W4214758967 |
| cited_by_count | 2 |
| counts_by_year[0].year | 2024 |
| counts_by_year[0].cited_by_count | 2 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1093/infdis/jiad534 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S54542293 |
| best_oa_location.source.issn | 0022-1899, 1537-6613 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0022-1899 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | The Journal of Infectious Diseases |
| best_oa_location.source.host_organization | https://openalex.org/P4310311648 |
| best_oa_location.source.host_organization_name | Oxford University Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| best_oa_location.source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiad534/54450191/jiad534.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | The Journal of Infectious Diseases |
| best_oa_location.landing_page_url | https://doi.org/10.1093/infdis/jiad534 |
| primary_location.id | doi:10.1093/infdis/jiad534 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S54542293 |
| primary_location.source.issn | 0022-1899, 1537-6613 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0022-1899 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | The Journal of Infectious Diseases |
| primary_location.source.host_organization | https://openalex.org/P4310311648 |
| primary_location.source.host_organization_name | Oxford University Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| primary_location.source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| primary_location.license | |
| primary_location.pdf_url | https://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiad534/54450191/jiad534.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | The Journal of Infectious Diseases |
| primary_location.landing_page_url | https://doi.org/10.1093/infdis/jiad534 |
| publication_date | 2023-11-29 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W3158948419, https://openalex.org/W3217094854, https://openalex.org/W3190427561, https://openalex.org/W4200248237, https://openalex.org/W3034680516, https://openalex.org/W3169651048, https://openalex.org/W4318149623, https://openalex.org/W3171257686, https://openalex.org/W4291634474, https://openalex.org/W4360839131, https://openalex.org/W3126303430, https://openalex.org/W3048117004, https://openalex.org/W4224221918, https://openalex.org/W4210317504, https://openalex.org/W4282914372 |
| referenced_works_count | 15 |
| abstract_inverted_index.2 | 15 |
| abstract_inverted_index.a | 41 |
| abstract_inverted_index.12 | 51 |
| abstract_inverted_index.78 | 38 |
| abstract_inverted_index.in | 88, 102 |
| abstract_inverted_index.is | 34 |
| abstract_inverted_index.of | 44, 47, 91, 99 |
| abstract_inverted_index.to | 9, 19, 60, 71 |
| abstract_inverted_index.HCs | 52, 78 |
| abstract_inverted_index.and | 50, 57, 77 |
| abstract_inverted_index.are | 93 |
| abstract_inverted_index.but | 23, 75 |
| abstract_inverted_index.for | 96 |
| abstract_inverted_index.had | 67 |
| abstract_inverted_index.key | 29 |
| abstract_inverted_index.map | 61 |
| abstract_inverted_index.HCs, | 74 |
| abstract_inverted_index.KTRs | 25, 39, 66, 76, 92 |
| abstract_inverted_index.from | 37, 40 |
| abstract_inverted_index.gaps | 87 |
| abstract_inverted_index.than | 73 |
| abstract_inverted_index.this | 103 |
| abstract_inverted_index.with | 32, 83 |
| abstract_inverted_index.Thus, | 85 |
| abstract_inverted_index.acute | 11 |
| abstract_inverted_index.doses | 46 |
| abstract_inverted_index.lower | 68 |
| abstract_inverted_index.phage | 54 |
| abstract_inverted_index.third | 45 |
| abstract_inverted_index.trial | 43 |
| abstract_inverted_index.(HCs), | 22 |
| abstract_inverted_index.(KTRs) | 4 |
| abstract_inverted_index.Kidney | 1 |
| abstract_inverted_index.Plasma | 36 |
| abstract_inverted_index.Trials | 107 |
| abstract_inverted_index.severe | 10 |
| abstract_inverted_index.titers | 8 |
| abstract_inverted_index.against | 28, 64 |
| abstract_inverted_index.breadth | 90 |
| abstract_inverted_index.develop | 5 |
| abstract_inverted_index.display | 55 |
| abstract_inverted_index.epitope | 86 |
| abstract_inverted_index.healthy | 20 |
| abstract_inverted_index.similar | 80 |
| abstract_inverted_index.whether | 24 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.Clinical | 106 |
| abstract_inverted_index.antibody | 7, 62, 69, 89 |
| abstract_inverted_index.clinical | 42 |
| abstract_inverted_index.compared | 18 |
| abstract_inverted_index.controls | 21 |
| abstract_inverted_index.efficacy | 98 |
| abstract_inverted_index.epitopes | 30, 81 |
| abstract_inverted_index.generate | 26 |
| abstract_inverted_index.syndrome | 13 |
| abstract_inverted_index.unknown. | 35 |
| abstract_inverted_index.unlikely | 94 |
| abstract_inverted_index.vaccines | 49, 101 |
| abstract_inverted_index.decreased | 6, 97 |
| abstract_inverted_index.responses | 63 |
| abstract_inverted_index.underwent | 53 |
| abstract_inverted_index.(PhIP-Seq) | 59 |
| abstract_inverted_index.SARS-CoV-2 | 48, 72, 100 |
| abstract_inverted_index.antibodies | 27 |
| abstract_inverted_index.associated | 31, 82 |
| abstract_inverted_index.reactivity | 70 |
| abstract_inverted_index.recipients | 3 |
| abstract_inverted_index.recognized | 79 |
| abstract_inverted_index.sequencing | 58 |
| abstract_inverted_index.transplant | 2 |
| abstract_inverted_index.SARS-CoV-2. | 65 |
| abstract_inverted_index.coronavirus | 14 |
| abstract_inverted_index.population. | 105 |
| abstract_inverted_index.respiratory | 12 |
| abstract_inverted_index.responsible | 95 |
| abstract_inverted_index.vaccination | 17 |
| abstract_inverted_index.(SARS-CoV-2) | 16 |
| abstract_inverted_index.NCT04969263. | 109 |
| abstract_inverted_index.Registration. | 108 |
| abstract_inverted_index.neutralization | 33 |
| abstract_inverted_index.neutralization. | 84 |
| abstract_inverted_index.immunosuppressed | 104 |
| abstract_inverted_index.immunoprecipitation | 56 |
| cited_by_percentile_year.max | 96 |
| cited_by_percentile_year.min | 94 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 14 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6899999976158142 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.64622346 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |